Saiseikai Matsuyama Hospital
Matsuyama, Ehime, Japan
General hospital in Matsuyama
880-2 Yamanishicho, Matsuyama, Ehime 791-8026
About Saiseikai Matsuyama Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Arena Pharmaceuticals
1
Eli Lilly and Company
1
Mebix Inc
1
Pfizer
1
Clinical Trials at Saiseikai Matsuyama Hospital
During the past decade, Saiseikai Matsuyama Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)
2013-06-01
Unknown status
220
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
2017-12-12
2019-10-11
Completed
162
A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
2017-12-13
2019-11-28
Completed
164
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
2021-05-10
2023-06-30
Active, not recruiting
261
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants
2021-08-18
2021-12-31
Completed
951
Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
2021-09-10
2023-12-01
Recruiting
96
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
2022-06-23
2024-06-28
Recruiting
807
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saiseikai Matsuyama Hospital" #1 sponsor was "Bayer" with 4 trials, followed by "Arena Pharmaceuticals" with 1 trials
sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Mebix Inc" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Matsuyama Hospital"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Saiseikai Matsuyama Hospital
According to Clinical.Site data, the most researched conditions in "Saiseikai Matsuyama Hospital" are
"Anemia" (2 trials), "Chronic Kidney Disease" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Saiseikai Matsuyama Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saiseikai Matsuyama Hospital
Most popular intervention types in "Saiseikai Matsuyama Hospital" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Darbepoetin alfa" (2 trials), "Etrasimod" (2 trials), "Molidustat (BAY85-3934)" (2 trials) and "Bisoprolol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saiseikai Matsuyama Hospital
The vast majority of trials in "Saiseikai Matsuyama Hospital" are
8 trials for "All" genders.
Clinical Trials Status at Saiseikai Matsuyama Hospital
Currently, there are NaN active trials in "Saiseikai Matsuyama Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Saiseikai Matsuyama Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saiseikai Matsuyama Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".